Viewing Study NCT01338792


Ignite Creation Date: 2025-12-24 @ 3:29 PM
Ignite Modification Date: 2026-01-19 @ 1:17 PM
Study NCT ID: NCT01338792
Status: COMPLETED
Last Update Posted: 2014-03-10
First Post: 2011-04-15
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer
Sponsor: University of Southern California
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 4P-05-7
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View